# Physiologic Effects of High Flow Nasal Therapy in Patients With Acute Hypoxemic Respiratory Failure (OPTIFLOW)

> **NCT01056952** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 12 (actual)

## Conditions studied

- Respiratory Failure

## Interventions

- **PROCEDURE:** O2stand
- **PROCEDURE:** CPAP
- **PROCEDURE:** Optiflow

## Key facts

- **NCT ID:** NCT01056952
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01056952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01056952, "Physiologic Effects of High Flow Nasal Therapy in Patients With Acute Hypoxemic Respiratory Failure (OPTIFLOW)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01056952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*